Menovo(SH:603538) Zheng Quan Ri Bao Wang·2026-01-23 10:48Core Viewpoint - Ningbo Meinuo Pharmaceutical Co., Ltd. announced that its subsidiaries have received the "High-tech Enterprise Certificate," allowing them to benefit from preferential tax policies for three years [1] Group 1: Company Announcements - Ningbo Meinuo's subsidiary Xuancheng Meinuo Pharmaceutical Co., Ltd. and its wholly-owned subsidiary Ningbo High-tech Zone Meinuo Pharmaceutical Innovation Research Institute Co., Ltd. received the high-tech enterprise certification [1] - The certification for Xuancheng Meinuo, the Innovation Research Institute, and Meinuo Tiankang is a re-certification following the expiration of their previous certificates [1] Group 2: Tax Benefits - The three companies will enjoy a corporate income tax rate of 15% for three years (2025, 2026, 2027) after obtaining the high-tech enterprise certification [1] - This tax benefit is in accordance with the "High-tech Enterprise Certification Management Measures" and the "Corporate Income Tax Law of the People's Republic of China" [1]